- £97.10m
- £540.67m
- $91.86m
- 24
- 90
- 80
- 75
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 119 | 135 | 118 | 112 | 91.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 41.9 | 64.9 | 180 | 22 | 19.1 |
Operating Profit | 77.2 | 70.4 | -62.7 | 90.2 | 72.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25.6 | 14.6 | -70.2 | 22.5 | 13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.7 | 9.72 | -84.9 | 17.1 | 12.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 25.7 | 9.71 | -84.9 | 17.1 | 12.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 25.7 | 9.71 | -84.9 | 17.1 | 12.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.299 | 0.492 | -0.364 | 0.34 | 0.077 |
Dividends per Share |